Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Effect of Valproic Acid Concentration on Photic Response

ClinicalTrials.gov ID: NCT00609245

Public ClinicalTrials.gov record NCT00609245. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 1:19 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Effect of Small Changes in Plasma Valproic Acid Concentration on the Photoparoxysmal Response

Study identification

NCT ID
NCT00609245
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Vanderbilt University Medical Center
Other
Enrollment
13 participants

Conditions and interventions

Interventions

  • Valproic Acid Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
15 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2007
Primary completion
Nov 30, 2008
Completion
Nov 30, 2008
Last update posted
Jun 13, 2017

2007 – 2008

United States locations

U.S. sites
2
U.S. states
2
U.S. cities
2
Facility City State ZIP Site status
The Comprehensive Epilepsy Care Center for Children & Adults Chesterfield Missouri 63017
Vanderbilt University Nashville Tennessee 37232

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00609245, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 13, 2017 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00609245 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →